Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jul;17(5):879-85.
doi: 10.1007/s10995-012-1066-z.

A national study of HPV vaccination of adolescent girls: rates, predictors, and reasons for non-vaccination

Laura M Kester  1 , Gregory D Zimet, J Dennis Fortenberry, Jessica A Kahn, Marcia L Shew
Affiliations

A national study of HPV vaccination of adolescent girls: rates, predictors, and reasons for non-vaccination

Laura M Kester et al. Matern Child Health J. 2013 Jul.

Abstract

Despite recommendations in the U.S. for routine HPV vaccination of adolescent girls since 2006, rates of vaccination continue to be low. This study reports vaccination uptake, factors associated with vaccine uptake and reasons for non-vaccination within a national sample of adolescent females during 2010. Using a computer administered survey of a national sample of 501 mothers of daughters 14-17 years old we assessed maternal reports of HPV vaccination as well as socio-demographical factors, maternal HPV exposures and reasons chosen for non-vaccination. Reported HPV vaccination rates were slightly over 50 % (51.1 %), with 38.3 % reporting completion of all 3 doses. Socioeconomic and demographic factors were not associated with vaccination initiation; however, Blacks and Hispanics were less likely to complete vaccination. The most common reasons for non-vaccination were concerns about vaccine safety, danger to daughter, and provider non-recommendation. Relatively poor HPV vaccine initiation and only modest 3-dose completion continues to be a major public health concern that requires continued efforts to address identified predictors and reasons for non-vaccination.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Sample Recruitment Process
See this image and copyright information in PMC

References

    1. Morbidity and Mortality Weekly Report(MMWR) Quadrivalent Human Papillomavirus Vaccine. RR02. Vol. 56. CDC; 2007. pp. 1–24. 2007. www.cdc.gov/mmwr/preview/mmwrhtml/rr5602a1.htm. - PubMed
    1. Morbidity and Mortality Weekly Report(MMWR) FDA Licensure of Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations from the Advisory Committee on Immunization Practices (ACIP) 2010. 20. Vol. 59. CDC; 2010. pp. 626–629. www.cdc.gov/mmwr/preview/mmwrhtml/mm5920a4.htm. - PubMed
    1. Morbidity and Mortality Weekly Report(MMWR) National Health and Nutrition Examination Survey, United States2003-2004. CDC; 2007. QuickStats: Prevalence of HPV Infection Among Sexually Active Females aged 14-59 Years by Age Group. www.cdc.gov/mmwr/preview/mmwrhtml/mm5633a5.htm.
    1. Weaver B, Shew M, Qadadri B, et al. Natural History of Multiple Human Papillomavirus Infections in Female Adolescents With Prolonged Follow-up. Journal of Adolescent Health. 2011;48(5):473–480. - PubMed
    1. Morbidity and Mortality Weekly Report(MMWR) National, State, and Local Area Vaccination Coverage among Adolescents Aged 13-17 Years --United States 2009. 32. Vol. 59. CDC; 2010. pp. 1018–1023. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6033a1.htm. - PubMed

Publication types

Substances